Filing Details
- Accession Number:
- 0001104659-25-043644
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-05-01 20:53:10
- Reporting Period:
- 2025-04-29
- Filing Date:
- 2025-05-01
- Accepted Time:
- 2025-05-01 20:53:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1657312 | Verona Pharma Plc | VRNA | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1337845 | Vikas Sinha | 3 More London Riverside London X0 SE1 2RE | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2025-04-29 | 15,048 | $1.70 | 89,488 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2025-04-29 | 15,048 | $8.92 | 74,440 | No | 4 | S | Direct | |
| Ordinary Shares | Acquisiton | 2025-04-29 | 4,952 | $0.50 | 79,392 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2025-04-29 | 4,952 | $8.92 | 74,440 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Share Options (Right to Buy) | Disposition | 2025-04-29 | 15,048 | $0.00 | 15,048 | $1.70 |
| Ordinary Shares | Share Options (Right to Buy) | Disposition | 2025-04-29 | 4,952 | $0.00 | 4,952 | $0.50 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 80,952 | 2027-04-26 | No | 4 | M | Direct | |
| 195,048 | 2032-04-27 | No | 4 | M | Direct |
Footnotes
- Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
- The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction adopted by the Reporting Person on November 6, 2024, solely with the intent to cover payment of the exercise price.
- Consists of 74,440 Ordinary Shares represented by 9,305 ADSs.
- The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
- The option is fully vested.
Billionaire Hedge Funds
